UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

---

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

---

Date of Report (Date of earliest event reported): May 29, 2012

Gulf Island Fabrication, Inc.
(Exact name of registrant as specified in its charter)

(985) 872-2100
(Registrant's telephone number, including area code)

N/A
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01         Other Events.

Gulf Island Fabrication, Inc. today announced that its Chairman of the Board and Chief Executive Officer, Kerry J. Chauvin, is being treated for low risk multiple myeloma.  Mr. Chauvin will undergo treatment at periodic intervals for a period of approximately six months.  Mr. Chauvin will continue to handle the day-to-day responsibilities as Chairman of the Board and Chief Executive Officer while maintaining regular communication with the Board of Directors regarding the progress of his treatment.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.